Table 3 Canonical pathways among rhesus macaque DMG in LN during chronic phase of the infection
Ingenuity canonical pathways | − log(p value) | Genes |
|---|---|---|
PTEN signaling | 4.73 | BCL2L1, CSNK2A1, GRB2, RPS6KB2, NFKB1, MAP2K1, PRKCZ |
PI3K/AKT signaling | 3.69 | BCL2L1, GRB2, RPS6KB2, NFKB1, MAP2K1, PRKCZ |
Acute myeloid leukemia signaling | 3.40 | KITLG, GRB2, RPS6KB2, NFKB1, MAP2K1 |
CD27 signaling in lymphocytes | 3.37 | BCL2L1, BID, NFKB1, MAP2K1 |
IGF-1 signaling | 3.07 | CSNK2A1, GRB2, RPS6KB2, MAP2K1, PRKCZ |
NGF signaling | 2.90 | GRB2, RPS6KB2, NFKB1, MAP2K1, PRKCZ |
ErbB4 signaling | 2.85 | YAP1, GRB2, MAP2K1, PRKCZ |
Role of NANOG in mammalian embryonic stem cell pluripotency | 2.83 | WNT3A, RIF1, WNT3, GRB2, MAP2K1 |
IL-15 signaling | 2.72 | BCL2L1, GRB2, NFKB1, MAP2K1 |
Erythropoietin signaling | 2.66 | GRB2, NFKB1, MAP2K1, PRKCZ |